Search research articles
Contact Us
Filters
Showing results (381-390 of 420) with videos related to
Page
of 42
Sort By:
World Journal of Urology
|
October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Minerva Urology and Nephrology
|
June 26, 2024
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
World Journal of Urology
|
November 18, 2024
Correction: Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Diagnostics (Basel, Switzerland)
|
March 25, 2022
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy
Matteo Ferro, Octavian Sabin Tătaru, Gennaro Musi, et al.
Journal of Cancer
|
December 7, 2018
Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer
Matteo Ferro, Giuseppe Di Lorenzo, Carlo Buonerba, et al.
Journal of Endourology
|
January 12, 2022
Robotic <i>vs</i> Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)
Alessandro Veccia, Umberto Carbonara, Hooman Djaladat, et al.
Urologic Oncology
|
May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Urologic Oncology
|
March 25, 2025
Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node status
Farshad Sheybaee Moghaddam, Rashid K Sayyid, Alireza Ghoreifi, et al.
Minerva Urology and Nephrology
|
October 5, 2022
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG
Roberto Contieri, Rodolfo Hurle, Marco Paciotti, et al.
World Journal of Urology
|
November 26, 2025
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registry
Margaret F Meagher, Zhenjie Wu, Antonio Franco, et al.
Page
of 42
Search research articles
Search
Showing results (381-390 of 420) with videos related to
Sort By:
Page
of 42
World Journal of Urology
|
October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Minerva Urology and Nephrology
|
June 26, 2024
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
World Journal of Urology
|
November 18, 2024
Correction: Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Diagnostics (Basel, Switzerland)
|
March 25, 2022
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy
Matteo Ferro, Octavian Sabin Tătaru, Gennaro Musi, et al.
Journal of Cancer
|
December 7, 2018
Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer
Matteo Ferro, Giuseppe Di Lorenzo, Carlo Buonerba, et al.
Journal of Endourology
|
January 12, 2022
Robotic <i>vs</i> Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)
Alessandro Veccia, Umberto Carbonara, Hooman Djaladat, et al.
Urologic Oncology
|
May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Urologic Oncology
|
March 25, 2025
Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node status
Farshad Sheybaee Moghaddam, Rashid K Sayyid, Alireza Ghoreifi, et al.
Minerva Urology and Nephrology
|
October 5, 2022
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG
Roberto Contieri, Rodolfo Hurle, Marco Paciotti, et al.
World Journal of Urology
|
November 26, 2025
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registry
Margaret F Meagher, Zhenjie Wu, Antonio Franco, et al.
Page
of 42